D. Kobayashi et al., CALCITONIN-GENE-RELATED PEPTIDE MEDIATED NEUROGENIC VASORELAXATION INTHE ISOLATED CANINE LINGUAL ARTERY, Japanese Journal of Pharmacology, 67(4), 1995, pp. 329-339
The nature of neurogenic relaxation was investigated in ring preparati
ons of canine lingual artery. In all experiments, the preparations wer
e previously treated with guanethidine (5 x 10(-6) M) to block neuroge
nic constrictor responses. In the presence of norepinephrine (10(-5) M
) to induce tone, electrical stimulation (10 V, 4 to 16 Hz, for 45 sec
) produced relaxation of the rings in an endothelium-independent fashi
on. The relaxant response in endothelium-denuded rings was not changed
by propranolol (10(-5) M), and atropine (10(-5) M) did not affect the
relaxation elicited by electrical stimulation in endothelium-intact r
ings. N-G-monomethyl-L-arginine (10(-4) M) or N-G-nitro-L-arginine met
hyl ester (10(-4) M), a nitric oxide (NO) synthase inhibitor, had no e
ffect on the electrical stimulation-induced relaxation of endothelium-
denuded rings. Human calcitonin gene-related peptide (CGRP)-(8 -37) (2
x 10(-8) M), a CGRP(1)-receptor antagonist, inhibited neurogenic rela
xation of endothelium-denuded rings; substance P (10(-6) M) failed to
mimic the observed effect of electrical stimulation. The demonstrated
effect of electrical stimulation was inhibited by glibenclamide (10(-5
) M), but not tetraethylammonium (2 x 10(-4) M); glibenclamide abolish
ed the relaxation in response to exogenous CGRP or the ATP-sensitive K
+ channel opener cromakalim (10(-6) M) in endothelium-denuded rings. M
oreover, tetrodotoxin (3.13 x 10(-6) M) inhibited the relaxation of en
dothelium-denuded rings induced by electrical stimulation. The relaxat
ion was selectively inhibited when endogenous CGRP had been depleted f
rom perivascular nerves by capsaicin (10(-6) M). These results suggest
that CGRP, but not NO, released from non-adrenergic non-cholinergic n
erves by electrical stimulation produces relaxation of canine lingual
artery that is mediated by activation of CGRP(1) receptors.